General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Ninety One UK Ltd Sells 412,050 Shares of Boston Scientific Co. (NYSE:BSX) | news.google.com • |
Closing Bell: Belo Sun Mining Corp flat on Tuesday (BSX) | news.google.com • |
Boston Scientific Corp. stock outperforms competitors despite losses on the day | news.google.com • |
Short Interest in Boston Scientific Co. (NYSE:BSX) Increases By 8.3% | news.google.com • |
Mackenzie Financial Corp Has $40.98 Million Position in Boston Scientific Co. (NYSE:BSX) | news.google.com • |
Boston Scientific (BSX) to Release Earnings on Wednesday | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-24 | 2024-03 | 0.51 | N/A | N/A | N/A |
2024-01-31 | 2023-12 | 0.51 | 0.55 | 0.04 | 7.84% |
2023-10-26 | 2023-09 | 0.48 | 0.5 | 0.02 | 4.17% |
2023-07-27 | 2023-06 | 0.49 | 0.53 | 0.04 | 8.16% |
2023-04-26 | 2023-03 | 0.43 | 0.47 | 0.04 | 9.30% |
2023-02-01 | 2022-12 | 0.47 | 0.45 | -0.02 | -4.26% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-21 | Barclays | Upgrade | Overweight | Overweight |
2023-09-20 | Needham | Upgrade | Buy | Buy |
2023-09-20 | BTIG | Upgrade | Buy | Buy |
2023-09-20 | RBC Capital | Upgrade | Outperform | Outperform |
2023-09-20 | Canaccord Genuity | Upgrade | Buy | Buy |
2023-09-20 | Citigroup | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-02-19 | BRENNAN DANIEL J | Chief Financial Officer | 271.54K | Sale |
2024-02-15 | BROWN VANCE R | General Counsel | 32.33K | Conversion of Exercise of derivative security |
2024-02-25 | BUTCHER ARTHUR C | Officer | 31.48K | Sale |
2024-03-31 | CARRUTHERS WENDY | Officer | 51.07K | Sale |
2024-02-15 | FITZGERALD JOSEPH MICHAEL | Officer | 265.74K | Conversion of Exercise of derivative security |
2024-02-15 | MAHONEY MICHAEL F | Chief Executive Officer | 1.85M | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 137.49M | 7.44B | 9.39% |
2023-06-29 | Vanguard Group Inc | 122.24M | 6.61B | 8.35% |
2023-06-29 | FMR, LLC | 117.88M | 6.38B | 8.05% |
2023-06-29 | Massachusetts Financial Services Co. | 69.14M | 3.74B | 4.72% |
2023-06-29 | State Street Corporation | 63.19M | 3.42B | 4.32% |
2023-06-29 | Wellington Management Group, LLP | 39.74M | 2.15B | 2.71% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 45.63M | 2.47B | 3.12% |
2023-06-29 | Vanguard 500 Index Fund | 34.23M | 1.85B | 2.34% |
2023-06-29 | Vanguard/Primecap Fund | 25.70M | 1.39B | 1.76% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 19.41M | 1.01B | 1.33% |
2023-05-30 | Fidelity 500 Index Fund | 16.03M | 825.11M | 1.09% |
2023-08-30 | SPDR S&P 500 ETF Trust | 15.84M | 854.44M | 1.08% |
Split | Date |
---|---|
2 : 1 | 2003-11-06 |
2 : 1 | 1998-12-01 |
All thanks to Mrs. Karen J Adams that helped me achieve my dreams through her trading program, I made over $30,000 in duration of 4 days she's so excellent and amazing. Visit her on TELEGRAM α¦αͺα‘α¬Ξ α« αͺα αͺα·Υ or WhatsApp +βΆβ½βΆβ·β·βΌβΏβ»β½βΏβΌ
Well.... that is some bullshit....
How many knew that Ocugen had a partnership which contractually GUARANTEES them revenues from Covid19 Antibody Testing?
(re: page 22 of annual report):
https://www.sec.gov/Archives/edgar/data/1372299/000110465920053502/tm2017927-1_10ka.htm
Collaboration with Advaite, Inc.
Β In April 2020, the Company entered into an agreement with Advaite, Inc., (Advaite) to provide certain support services for Advaite's development of a diagnostic test kit that is designed to detect antibodies to COVID-19. ...{Ocugen}... will receive tiered royalty payments based on cumulative net sales of the test kit.
The projected market for Covid diagnostic testing is $61B AND GROWING!
MORE IMPORTANTLY Advaite is NOW MOVING on Covid Antibody Testing!
https://www.linkedin.com/mwlite/company/advaite
*
The BEAUTY here:
NOBODY KNOWS Ocugen will be collecting potentially BILLION$ in COVID DIAGNOSTICS revenue! They NEVER did a PRESS RELEASE!